EXPLORE CONNECTIONS
Cancer phase I trial design using drug combinations when a fraction of dose limiting toxicities is attributable to one or more agents
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.